中国药品检查人员的培训和实践:经验,挑战和发展
Jinyao Sun1, Lubo Guo2, Zhixiang Shi3
1Department of Training, School of Continuing Education, China Pharmaceutical University, Nanjing, China.
Frontiers in medicine
|June 19, 2025
概括
有效的药品检查依赖于熟练的药品检查员. 这项研究考察了中国.
科学领域:
- 制药法规和药物安全问题
- 公共卫生政策 公共卫生政策
- 专业培训和发展专业培训和发展
背景情况:
- 药品检查员的能力直接影响检查质量和药品安全.
- 有效的监督需要有资格的药物检查员,具有强大的培训和管理能力.
- 目前在中国的药品检查员培训面临着特定的挑战和机遇.
研究的目的:
- 分析中国药品检查员培训和实践的现状.
- 确定该领域的最新发展和成就.
- 为加强药品检查员培训系统提出建议.
主要方法:
- 审查目前在中国的药品检查员培训计划.
- 分析近期药品检查员培训方面的发展和成就.
- 检查现有系统中的挑战和机会.
- 制定改善系统的建议.
主要成果:
- 近年来,中国的药品检查员培训取得了发展和成就.
- 在当前的培训框架内存在特定的挑战和机会.
- 该研究确定了提高资格,培训和管理能力的领域.
结论:
- 提高药品检查员培训对于提高整体质量和现代化检查能力至关重要.
- 系统的培训和标准化的管理是有效的药物监督的关键.
- 建议旨在为提高中国药品检查员能力提供见解.
更多相关视频
05:54Controlled Odor Mimic Permeation Systems for Olfactory Training and Field Testing
Published on: January 28, 2021
4.7K
04:19Author Spotlight: An Improved Technique for Trimethylamine Detection in Animal-Derived Medicine by Headspace Gas Chromatography-Tandem Quadrupole Mass Spectrometry
Published on: March 10, 2023
2.0K
相关概念视频
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Drug Control Governance: Regulatory Bodies and Their Impact
258
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
258
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Drug Concentrations: Measurements
617
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
617
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
